4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Intelligent Bio Solutions Inc. (INBS) operates in the Medical Devices industry and is headquartered in New York, United States with about 59 employees. Its market capitalization is roughly $7 million. In the fiscal year ended 2026-06-30, INBS reported $4M in revenue and ($12M) in net income.
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally.
Interactive charts & full statements → Open the INBS valuation workbench →
| Income statement | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Total Revenue | $4M | $3M | $3M | $1M | — |
| Gross Profit | $2M | $1M | $1M | $0M | — |
| Operating Income (EBIT) | ($12M) | ($10M) | ($10M) | ($8M) | — |
| Net Income | ($12M) | ($11M) | ($10M) | ($11M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $1M | $1M | $1M | $1M | $1M | — |
| Gross Profit | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($3M) | ($3M) | ($3M) | ($3M) | ($3M) | — |
| Net Income | ($3M) | ($3M) | ($3M) | ($3M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Total Assets | $12M | $8M | $14M | $10M | — |
| Total Liabilities | $7M | $5M | $6M | $7M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive INBS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms